Phase 4Active, not recruitingHealthspan endpoint

GLP-1s to Enhance Lasting Optimal Weight (GLOW)

Effects of Tirzepatide on Fat-Free Mass, Bone and Physical Function in Older Adults - a Pilot Study

Sponsor
Wake Forest University Health Sciences (Academic or other)
Enrollment
40 enrolled
Conditions
Obesity
Interventions
Tirzepatide
Ages
older adults
Registry
NCT06861439

Full record on ClinicalTrials.gov

From the registry

The goal of this study is to examine how tirzepatide affects body composition, bone health, and physical performance in older adults over a nine-month period. Participants will take tirzepatide weekly, have clinic visits every 4 weeks, meet study doctor and registered dietitian every 4 weeks in person or video conference, attend group intervention sessions twice a month via video conference, weigh daily with a study-provided smart scale, keep a record of all foods and beverages consumed, and use a study-provided activity tracker to keep track of daily step counts.

Primary outcomes

  • Change in total body lean mass
  • Change in appendicular lean mass
  • Change in total body fat mass
  • Change in total hip bone mineral density

History

  1. Study completion expected

  2. Primary completion expected

  3. Last registry update

  4. Started

  5. Registered

In the news